• 4-Feb-2026 Proposed issue of securities - CYC Proposed issue of securities - CYC
• 4-Feb-2026 Cyclopharm Capital Raising Investor Presentation Cyclopharm Capital Raising Investor Presentation
• 4-Feb-2026 Cyclopharm Successfully Completes A$14 million Placement Cyclopharm Successfully Completes A$14 million Placement
• 2-Feb-2026 CYC Unaudited Trading Update - Preliminary FY2025 Results CYC Unaudited Trading Update - Preliminary FY2025 Results
• 2-Feb-2026 Trading Halt Trading Halt
• 29-Jan-2026 COPD Study Leveraging Technegas and AI-Driven Lung Analysis COPD Study Leveraging Technegas and AI-Driven Lung Analysis
• 27-Jan-2026 Technegas Recognised in Updated Clinical Guideline Technegas Recognised in Updated Clinical Guideline
• 27-Jan-2026 Insurer Indemnifies Cyclopharm Insurer Indemnifies Cyclopharm
• 12-Jan-2026 Stanford Children's Health to Implement Technegas Stanford Children's Health to Implement Technegas
• 22-Dec-2025 Colombia Approval Marks 67th Country for Technegas Colombia Approval Marks 67th Country for Technegas
• 21-Nov-2025 Technegas Asthma Trial Commences in Canada Technegas Asthma Trial Commences in Canada
• 19-Nov-2025 Cyclopharm Bell Potter Healthcare Conference Presentation Cyclopharm Bell Potter Healthcare Conference Presentation

Click here for archives